These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

261 related articles for article (PubMed ID: 16211709)

  • 21. Risk of death associated with nesiritide in patients with acutely decompensated heart failure.
    Aaronson KD; Sackner-Bernstein J
    JAMA; 2006 Sep; 296(12):1465-6. PubMed ID: 17003394
    [No Abstract]   [Full Text] [Related]  

  • 22. In brief: nesiritide (Natrecor).
    Med Lett Drugs Ther; 2011 Nov; 53(1377):92. PubMed ID: 22089926
    [No Abstract]   [Full Text] [Related]  

  • 23. Controversy and conflict in the treatment of acute decompensated heart failure: limited role for nesiritide.
    Noviasky JA
    Pharmacotherapy; 2007 May; 27(5):626-32. PubMed ID: 17461696
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The ASCEND-HF trial: an acute study of clinical effectiveness of nesiritide and decompensated heart failure.
    Dandamudi S; Chen HH
    Expert Rev Cardiovasc Ther; 2012 May; 10(5):557-63. PubMed ID: 22651831
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Impact of nesiritide on renal function and mortality in patients suffering from heart failure.
    Dontas ID; Xanthos T; Dontas I; Lelovas P; Papadimitriou L
    Cardiovasc Drugs Ther; 2009 Jun; 23(3):221-33. PubMed ID: 19252976
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Nesiritide in acute decompensated heart failure.
    Kramer DB
    N Engl J Med; 2011 Oct; 365(16):1547; discussion 1547. PubMed ID: 22010930
    [No Abstract]   [Full Text] [Related]  

  • 27. Nesiritide for acute decompensated heart failure.
    Alhosaini H
    Am Fam Physician; 2006 Oct; 74(8):1279; author reply 1279-80. PubMed ID: 17087421
    [No Abstract]   [Full Text] [Related]  

  • 28. Nesiritide, heart failure, and renal dysfunction: irrational exuberance or throwing the baby out with the bathwater. Editorial to: "Impact of nesiritide on renal function and mortality in patients suffering from heart failure" by Dontas et al.
    Witteles RM
    Cardiovasc Drugs Ther; 2009 Jun; 23(3):183-6. PubMed ID: 19353257
    [No Abstract]   [Full Text] [Related]  

  • 29. Rationale and design of the Acute Study of Clinical Effectiveness of Nesiritide in Decompensated Heart Failure Trial (ASCEND-HF).
    Hernandez AF; O'Connor CM; Starling RC; Reist CJ; Armstrong PW; Dickstein K; Lorenz TJ; Gibler WB; Hasselblad V; Komajda M; Massie B; McMurray JJ; Nieminen M; Rouleau JL; Swedberg K; Califf RM
    Am Heart J; 2009 Feb; 157(2):271-7. PubMed ID: 19185633
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Dyspnea as an end point in clinical trials of therapies for acute decompensated heart failure.
    Teerlink JR
    Am Heart J; 2003 Feb; 145(2 Suppl):S26-33. PubMed ID: 12594449
    [No Abstract]   [Full Text] [Related]  

  • 31. B-natriuretic peptide in the management of heart failure.
    Armstrong J; Graber MA
    JAAPA; 2003 Jun; 16(6):35-9, 44. PubMed ID: 14968503
    [No Abstract]   [Full Text] [Related]  

  • 32. B-type natriuretic peptide: from bench to bedside.
    Adams KF; Mathur VS; Gheorghiade M
    Am Heart J; 2003 Feb; 145(2 Suppl):S34-46. PubMed ID: 12594450
    [No Abstract]   [Full Text] [Related]  

  • 33. Nesiritide in acute decompensated heart failure: to use or not to use, that is the question?
    Kapoor JR
    Am J Cardiol; 2007 Aug; 100(4):745-6. PubMed ID: 17697845
    [No Abstract]   [Full Text] [Related]  

  • 34. Nesiritide speeds recovery time for heart failure patients.
    Morrow T
    Manag Care; 2004 Jul; 13(7):60-1. PubMed ID: 15347161
    [No Abstract]   [Full Text] [Related]  

  • 35. Nesiritide in patients with acute myocardial infarction and heart failure: a meta-analysis.
    Zhao X; Zhang DQ; Song R; Zhang G
    J Int Med Res; 2020 Jan; 48(1):300060519897194. PubMed ID: 31948318
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Is nesiritide really that good or that bad?
    Cheng TO
    Am Heart J; 2006 Apr; 151(4):e1; author reply e3. PubMed ID: 16569525
    [No Abstract]   [Full Text] [Related]  

  • 37. Intermittent outpatient nesiritide infusion reduces hospital admissions in patients with advanced heart failure.
    Schwarz ER; Najam S; Akel R; Sulimanjee N; Bionat S; Rosanio S
    J Cardiovasc Pharmacol Ther; 2007 Sep; 12(3):232-6. PubMed ID: 17875951
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Critical review and recommendations for nesiritide use in the emergency department.
    Collins SP; Hinckley WR; Storrow AB
    J Emerg Med; 2005 Oct; 29(3):317-29. PubMed ID: 16183453
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Hemodynamic effects and safety of nesiritide in neonates with heart failure.
    Simsic JM; Mahle WT; Cuadrado A; Kirshbom PM; Maher KO
    J Intensive Care Med; 2008; 23(6):389-95. PubMed ID: 18805856
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Is there a use for nesiritide in pediatric patients?
    Schamberger MS
    J Intensive Care Med; 2004; 19(3):171-3. PubMed ID: 15154998
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.